SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-063025
Filing Date
2023-11-13
Accepted
2023-11-13 16:30:42
Documents
60
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q clsd-20230930.htm   iXBRL 10-Q 1533407
2 EX-31.1 clsd-ex31_1.htm EX-31.1 15762
3 EX-31.2 clsd-ex31_2.htm EX-31.2 15460
4 EX-32.1 clsd-ex32_1.htm EX-32.1 10224
5 GRAPHIC img141480856_0.jpg GRAPHIC 85892
  Complete submission text file 0000950170-23-063025.txt   6015803

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT clsd-20230930_def.xml EX-101.DEF 179993
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clsd-20230930.xsd EX-101.SCH 54090
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT clsd-20230930_cal.xml EX-101.CAL 31955
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clsd-20230930_lab.xml EX-101.LAB 408333
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clsd-20230930_pre.xml EX-101.PRE 298684
54 EXTRACTED XBRL INSTANCE DOCUMENT clsd-20230930_htm.xml XML 859481
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37783 | Film No.: 231399326
SIC: 2834 Pharmaceutical Preparations